Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.28% Nasdaq 0.00%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS

88.49 Up 0.02(0.02%) Jun 21, 4:00PM EDT|After Hours : 88.70 Up 0.21 (0.24%) Jun 21, 7:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 1,134,114   783,431   540,957  
Cost of Revenue72,837  93,140  64,437  
Gross Profit 1,061,277   690,291   476,520  
Operating Expenses
Research Development222,732  137,421  98,394  
Selling General and Administrative384,678  308,176  226,766  
Non Recurring49,112  13,486  722  
Others417  382   -  
Total Operating Expenses656,939  459,465   -  
Operating Income or Loss 404,338   230,826   150,638  
Income from Continuing Operations
Total Other Income/Expenses Net630  (370)(923)
Earnings Before Interest And Taxes404,968  230,456  149,715  
Interest Expense7,402  788  704  
Income Before Tax397,566  229,668  149,011  
Income Tax Expense142,744  54,353  51,981  
Minority Interest -   -   -  
Net Income From Continuing Ops254,822  175,315  97,030  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 254,822   175,315   97,030  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 254,822   175,315   97,030  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.